Phialophora verrucosa
Phialophora verrucosa is a fungal species belonging to the Phialophora genus. It is a dematiaceous (darkly pigmented) fungus known for causing a type of fungal infection called chromoblastomycosis, particularly in tropical and subtropical regions.
Taxonomy[edit]
The species was first described in the scientific literature in the early 20th century. It belongs to the Phialophora genus, which is part of the Herpotrichiellaceae family. The genus name Phialophora refers to the characteristic flask-shaped phialides that these fungi produce.
Morphology[edit]
Phialophora verrucosa is a dematiaceous fungus, meaning it has darkly pigmented hyphae. It produces characteristic flask-shaped phialides, which give rise to conidia (asexual spores). The conidia are typically oval in shape and are produced in a distinctive "bottle-brush" arrangement.
Pathogenicity[edit]
Phialophora verrucosa is one of the causative agents of chromoblastomycosis, a chronic fungal infection of the skin and subcutaneous tissue. The disease is most commonly seen in tropical and subtropical regions, particularly in rural areas where individuals are frequently exposed to soil and plant material.
Infection typically occurs following traumatic implantation of the fungus into the skin. The disease is characterized by the formation of warty, verrucous lesions, often on the limbs. Diagnosis is typically made by histopathological examination of a biopsy specimen, with the presence of characteristic "sclerotic bodies" being indicative of chromoblastomycosis.
Treatment[edit]
Treatment of infections caused by Phialophora verrucosa can be challenging and often requires a combination of surgical and medical therapies. Antifungal drugs such as Itraconazole and Terbinafine are commonly used, often in combination with surgical debridement of the affected area.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

